Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure

Research - Initial Experience of Intravesical Gemcitabine for Patients With High-Risk Superficial Transitional Cell Carcinoma Of the Bladder Following BCG Failure


Identification: unj_ma14_05
Issue: March-April 2014
Volume: Volume 34 Number 2

Standard: $15.00

Author(s)

Speaker(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content

References